Adult primary liver sarcoma: systematic review

ABSTRACT Introduction: primary liver sarcoma is a rare type of tumor, more common in children. Among adults, it represents a spectrum of neoplasms with reserved prognosis. There is no consensus on the treatment of choice of these lesions, justifying a systematic review of the literature on treatment options, prognostic factors, and survival. Material/Methods: a systematic review of articles published in Pubmed, Medline, LiLacs e SciElo, from 1966 to March/2019, presenting the keywords: primary-liver-sarcoma and primary-hepatic-sarcoma was undertaken. Studies including patients older than 18 years, and published in English, Portuguese and Spanish were included. Case reports, metastatic tumors and multiple oncologic diagnosis were excluded. The initial search listed 1,318 articles. 1,206 did not meet the inclusion criteria. After reviewing 112 eligible articles, 15 were selected (14 case series and 1 retrospective-cohort). Results: proposed treatment modalities for primary liver sarcoma included surgery and/or chemotherapy and/or radiotherapy or liver transplantation. The most common histological types were angiosarcoma (32%), leiomyosarcoma (29%), epithelioid hemangioendothelioma (15%) and embryonal sarcoma (7%). Histology, degree of differentiation and R0 resection were mentioned positive prognostic factors. Median survival ranged from two to 23 months. Five-year survival rate varied from 0% to 64%, on average 21%. Conclusion: surgical resection (R0 resection) is the main treatment for primary liver sarcomas. Development of effective systemic therapies are required to improve prognosis of patients harboring this type of tumor.

Saved in:
Bibliographic Details
Main Authors: MARTINS,ANTONIO CAVALCANTI DE ALBUQUERQUE, COSTA NETO,DUÍLIO CABRAL DA, SILVA,JÚLIO DOURADO DE-MATOS E, MORAES,YGOR MONTEIRO, LEÃO,CRISTIANO SOUZA, MARTINS,CAROLINA
Format: Digital revista
Language:English
Published: Colégio Brasileiro de Cirurgiões 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912020000100208
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-69912020000100208
record_format ojs
spelling oai:scielo:S0100-699120200001002082020-11-30Adult primary liver sarcoma: systematic reviewMARTINS,ANTONIO CAVALCANTI DE ALBUQUERQUECOSTA NETO,DUÍLIO CABRAL DASILVA,JÚLIO DOURADO DE-MATOS EMORAES,YGOR MONTEIROLEÃO,CRISTIANO SOUZAMARTINS,CAROLINA Liver Sarcoma Liver Neoplasms Systematic Review ABSTRACT Introduction: primary liver sarcoma is a rare type of tumor, more common in children. Among adults, it represents a spectrum of neoplasms with reserved prognosis. There is no consensus on the treatment of choice of these lesions, justifying a systematic review of the literature on treatment options, prognostic factors, and survival. Material/Methods: a systematic review of articles published in Pubmed, Medline, LiLacs e SciElo, from 1966 to March/2019, presenting the keywords: primary-liver-sarcoma and primary-hepatic-sarcoma was undertaken. Studies including patients older than 18 years, and published in English, Portuguese and Spanish were included. Case reports, metastatic tumors and multiple oncologic diagnosis were excluded. The initial search listed 1,318 articles. 1,206 did not meet the inclusion criteria. After reviewing 112 eligible articles, 15 were selected (14 case series and 1 retrospective-cohort). Results: proposed treatment modalities for primary liver sarcoma included surgery and/or chemotherapy and/or radiotherapy or liver transplantation. The most common histological types were angiosarcoma (32%), leiomyosarcoma (29%), epithelioid hemangioendothelioma (15%) and embryonal sarcoma (7%). Histology, degree of differentiation and R0 resection were mentioned positive prognostic factors. Median survival ranged from two to 23 months. Five-year survival rate varied from 0% to 64%, on average 21%. Conclusion: surgical resection (R0 resection) is the main treatment for primary liver sarcomas. Development of effective systemic therapies are required to improve prognosis of patients harboring this type of tumor.info:eu-repo/semantics/openAccessColégio Brasileiro de CirurgiõesRevista do Colégio Brasileiro de Cirurgiões v.47 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912020000100208en10.1590/0100-6991e-20202647
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author MARTINS,ANTONIO CAVALCANTI DE ALBUQUERQUE
COSTA NETO,DUÍLIO CABRAL DA
SILVA,JÚLIO DOURADO DE-MATOS E
MORAES,YGOR MONTEIRO
LEÃO,CRISTIANO SOUZA
MARTINS,CAROLINA
spellingShingle MARTINS,ANTONIO CAVALCANTI DE ALBUQUERQUE
COSTA NETO,DUÍLIO CABRAL DA
SILVA,JÚLIO DOURADO DE-MATOS E
MORAES,YGOR MONTEIRO
LEÃO,CRISTIANO SOUZA
MARTINS,CAROLINA
Adult primary liver sarcoma: systematic review
author_facet MARTINS,ANTONIO CAVALCANTI DE ALBUQUERQUE
COSTA NETO,DUÍLIO CABRAL DA
SILVA,JÚLIO DOURADO DE-MATOS E
MORAES,YGOR MONTEIRO
LEÃO,CRISTIANO SOUZA
MARTINS,CAROLINA
author_sort MARTINS,ANTONIO CAVALCANTI DE ALBUQUERQUE
title Adult primary liver sarcoma: systematic review
title_short Adult primary liver sarcoma: systematic review
title_full Adult primary liver sarcoma: systematic review
title_fullStr Adult primary liver sarcoma: systematic review
title_full_unstemmed Adult primary liver sarcoma: systematic review
title_sort adult primary liver sarcoma: systematic review
description ABSTRACT Introduction: primary liver sarcoma is a rare type of tumor, more common in children. Among adults, it represents a spectrum of neoplasms with reserved prognosis. There is no consensus on the treatment of choice of these lesions, justifying a systematic review of the literature on treatment options, prognostic factors, and survival. Material/Methods: a systematic review of articles published in Pubmed, Medline, LiLacs e SciElo, from 1966 to March/2019, presenting the keywords: primary-liver-sarcoma and primary-hepatic-sarcoma was undertaken. Studies including patients older than 18 years, and published in English, Portuguese and Spanish were included. Case reports, metastatic tumors and multiple oncologic diagnosis were excluded. The initial search listed 1,318 articles. 1,206 did not meet the inclusion criteria. After reviewing 112 eligible articles, 15 were selected (14 case series and 1 retrospective-cohort). Results: proposed treatment modalities for primary liver sarcoma included surgery and/or chemotherapy and/or radiotherapy or liver transplantation. The most common histological types were angiosarcoma (32%), leiomyosarcoma (29%), epithelioid hemangioendothelioma (15%) and embryonal sarcoma (7%). Histology, degree of differentiation and R0 resection were mentioned positive prognostic factors. Median survival ranged from two to 23 months. Five-year survival rate varied from 0% to 64%, on average 21%. Conclusion: surgical resection (R0 resection) is the main treatment for primary liver sarcomas. Development of effective systemic therapies are required to improve prognosis of patients harboring this type of tumor.
publisher Colégio Brasileiro de Cirurgiões
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912020000100208
work_keys_str_mv AT martinsantoniocavalcantidealbuquerque adultprimaryliversarcomasystematicreview
AT costanetoduiliocabralda adultprimaryliversarcomasystematicreview
AT silvajuliodouradodematose adultprimaryliversarcomasystematicreview
AT moraesygormonteiro adultprimaryliversarcomasystematicreview
AT leaocristianosouza adultprimaryliversarcomasystematicreview
AT martinscarolina adultprimaryliversarcomasystematicreview
_version_ 1756389401880952832